XOMA – Startup Investor Profile

XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation

Location: Berkeley

Country:

Investment Regions:

Investment Stages: late-stage, pre-seed, seed, series-a

Website: http://www.xoma.com/

AI Reasoning: Search of XOMA (XOMA Royalty Corporation) news and press releases shows purchases/transactions in 2025 (e.g., 2025 press releases and royalty receipts reported Aug 13, 2025) but no evidence of direct investments into startups in the last 12 months. The most recent specific purchase agreement press release found on the XOMA site shows activity in 2023 (raise with Blue Owl Capital Dec 19, 2023) and company reporting through 2025 relates to royalties/transactions rather than new startup investments. The last explicit transaction tied to acquiring payment rights dates to October 7, 2021; while XOMA reported receipts and deals in 2025, there is no clear record of a new investment into a startup within the past 12 months. Therefore the investor’s last clearly identifiable investment-like transaction is older than 12 months (e.g., 2023/2021), so classify as not-active.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.